Page 44 - Book Value News Today

CRISPR Therapeutics AG is a gene editing company based on CRISPR/Cas9 technology. Read more to see why my rating is a buy on CRSP stock.

The decline of many stocks in 2022 has created buying opportunities.

The decline of many stocks in 2022 has created buying opportunities.

Is stx sam and the third letter of course is that the area of political machine of gavin newsom and nancy pelosi income kamala harris. and dianne feinstein. so put on the street together and they exercise a lot of power and they are exempt from the rules apply. everybody else due to prestige and money, and political power and influence. >> charlie, before you comment i you know you have a lot to say here, but i want people who have responded disclose who arent invested in crypto and scared off b...

Earnings of Community Trust Bancorp will likely climb next year on the back of commercial loan growth. See why I'm downgrading CTBI stock to a Hold rating.

LCNB Corp.'s loan growth outlook is mixed, but earnings should increase next year. Click here to see why I’m maintaining a buy rating on LCNB stock.

Simmons First National's net interest margin grew by only 10 basis points in the third quarter to 3.34%. See why I'm upgrading SFNC stock to a buy rating.

It still needs to prove that its lead program is as effective as it claims for treating Alzheimer's.

Mortgage REITs - which were left for dead amid a historically brutal year across fixed-income markets - have rebounded in recent weeks. Click here to read more.

OTTAWA, Ill., Nov. 16, 2022 (GLOBE NEWSWIRE) -- Ottawa Bancorp, Inc. (the “Company”) (OTCQX: OTTW), the holding company for OSB Community Bank (the...